---
title: "Ozagrel - Spasm of cerebral arteries"
sidebar: mydoc_sidebar
permalink: db12017-mesh-d020301-1.html
toc: false 
---


Path ID: `DB12017_MESH_D020301_1`
{% include image.html url="images/db12017-mesh-d020301-1.png" file="db12017-mesh-d020301-1.png" alt="db12017-mesh-d020301-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C034364 | Ozagrel | Drug |
| MESH:D013928 | Thromboxane A2 | ChemicalSubstance |
| GO:0070527 | Platelet aggregation | BiologicalProcess |
| GO:0042311 | Vasodilation | BiologicalProcess |
| HP:0002637 | Cerebral ischemia | PhenotypicFeature |
| MESH:D020301 | Spasm of cerebral arteries | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ozagrel | DECREASES SYNTHESIS OF | Thromboxane A2 |
| Thromboxane A2 | PREVENTS | Platelet Aggregation |
| Platelet Aggregation | POSITIVELY REGULATES | Vasodilation |
| Vasodilation | AMELIORATES | Cerebral Ischemia |
| Cerebral Ischemia | CORRELATED WITH | Spasm Of Cerebral Arteries |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB12017#mechanism-of-action](https://go.drugbank.com/drugs/DB12017#mechanism-of-action){:target="_blank"}